Male rats were repeatedly given 1, 2-dibromo-3-chloropropane (DBCP)
INTRODUCTION
1,2-dibromo-3-chloropropane (DBCP) has been widely used as a soil fumigant, but its use was prohibited because of the high incidence of infertility and testicular atrophy in occupationally exposed workers.1-3) Sperm count depression was also reported in pesticide applyers as well as agricultural workers.4-6) A recent followup study of workers exposed to the pesticide indicated that its effects most likely are permanent') In experimental studies, DBCP has induced acute injuries in the liver, kidney, testis, epididymis, intestine and lympho-hematopoietic system.8-11) After inhalation of DBCP, the respiratory system was also involved.12,13) There are reports on the development of stomach cancer after gastric intubation of DBCP14) and of nasal and lung cancer after its inhalation.15,16) Although our previous11) and experiments by others9,10) suggest that the toxic effects of DBCP on the kidney and testis may be cumulative, no systemic study of such effects has been reported. So an experiment focusing on the cumulative effects of DBCP was performed. This paper deals with the pathological changes in male rats repeatedly exposed to relatively low doses of DBCP. Hematology and serum analyses Rats were deeply anesthetized by intraperitoneal injection of 50 mg/kg sodium pentobarbital (Abbot Laboratory, Illinois, U.S.A.) and bled by heart puncture. Samples of the blood were heparinized to count red blood cells (RBC) and white blood cells (WBC) by automatic blood cell counter (Towa Science, Tokyo). Sera were analyzed for creatinine and urea nitrogen (BUN) concentrations and for glutamic pyruvic transaminase (GPT) and glutamic oxaloacetic transaminase (GOT) activities by spectrophotemetric methods using commercial kits (Boehringer Mannheim Japan, Tokyo). 
MATERIALS AND METHODS

RESULTS
Body weight and clinical features Weight gain was suppressed dose-dependently in DBCP-treated rats (Fig. 1) . Rats treated with 100 mg/kg slightly lost body weights during the initial 3 weeks. They gained the body weight thereafter, while no weight gain occurred after the 9th week until the end of exposure.
Rats treated with 30 mg/kg slightly lost their weights after the 9th week of exposure. Considerable weight gain was noted in all animals after DBCP exposure, though dose-dependent suppression of weight gain was prominent throughout the experiment. In rats treated with 100 mg/kg, alopecia appeared on the face, shoulder and back after the 2nd week until the 14th week. The incidence and severity increased CUMULATIVE EFFECTS OF DBCP 51 time-dependently during the exposure, and 7 of 15 rats at most were involved. Solid tumors at the injection sites developed in 2 of 5 rats treated with 100 mg/kg and 1 of 5 treated with 30 mg/kg after the 30th, 32nd and 34th week of the experiment, respectively.
Hematology and serum analyses
Marked leukopenia appeared at the 12th week in rats treated with 100 mg/kg (Table 1) . Leukocytosis (39,000 and 69,200 WBC/mm3) was noticed in two rats bearing subcutaneous tumors at the 36th week, and anemia (455 x 10' RBC/mm') also appeared in one of them. There was no hematological abnormality in the other rats.
Serum GPT and GOT activities as well as BUN concentrations were stable in all groups during the experiment.
However, slight but significant increases in creatinine concentrations were noted throughout the experiment in rats treated with 100 mg/kg (Table 2) .
Organ weights and Gross findings
The relative weight (relative to body weight ratio) of kidneys at the 12th week increased dose-dependently (Table 3) . The relative testicular weight in rats treated with 100 mg/kg was severely decreased throughout the experiment, whereas those treated with less than 30 mg/kg were similar to that of control. A dose-dependent decrease in relative thymic weight also occurred at the 12th week. Enlarged and pale kidneys appeared at the 12th week in all rats treated with 100 mg/kg. Testicular atrophy appeared throughout the obser\ ation in rats treated with 100 mg/kg and was markedly prominent in 3, 4 and 3 cases at the 12th, 24th and 36th week, respectively. The epididymides attached to these small testes were also markedly atrophic. Subcutaneous solid tumors at the injected sites were found at the 36th week in 3 of 5 rats treated with 100 mg/kg and in 1 of 5 treated with 30 mg/kg.
Histopathology
Marked changes caused by DBCP were found in kidneys and testes. Primary renal lesions occurred in the outer medulla, though additional foci also appeared in the cortexes of the rats treated with 100 mg/kg.
In the rats treated with 100 mg/kg, the proximal tubules at the pars recta were lined by enlarged or bizarre giant epithelial cells with brush border and enormous nuclei 5 to 10 times normal size (Fig. 2D) . Frequent degeneration and necrosis of these giant cells occurred, resulting in dilation of the tubules. Similar but less severe lesions were detected in the cortexes in these animals. Renal lesions in the rats treated with less than 30 mg/kg were limited to the pars recta, being qualitatively similar to those treated with 100 mg/kg but the quantitative effect was less severe dosedependently (Fig. 2) .
In the testes of rats treated with 100 mg/kg, there was total atrophy of the seminiferous tubules with occasional interstitial edema in 3, 4 and 3 rats at the 12th, 24th and 36th week, respectively (Fig. 3) . These tubules contained only degenerative Sertoli cells with thickened lamina propria.
The other cases had a mixture of tubules that were atrophied, regenerating or normal but with diameters smaller than normal. In some tubules, necrotic or degenerative epithelium occasionally became detached into the lumen and degenerative spermatids often coalesced into multinucleated giant cells. There were a few atrophic seminiferous tubules in 4, 2 and 5 rats treated with 30 mg/kg, and 1, 1, and 2 rats treated with 10 mg/kg at the 12th, 24th and 36th week, respectively. Additional changes seen in rats treated with 100 mg/kg were marked depletion of lymphocytes in the thymic cortex, splenic white pulp and paracortical areas in lymph nodes, frequent epithelial necrosis in the proliferative zone of crypts of Lieberkhun in the duodenum at hte 12th week. Slight but diffuse swelling of hepatocytes with focal necrosis also occurred in 2 of 5 cases at the 12th week. At the 36th week, myeloid metaplasia of splenic red pulp appeared in a rat having a subcutaneous tumor and severe anemia. Subcutaneous tumors in 4 cases were diagnosed as malignant fibrous histiocytoma. 
DISCUSSION
Previous studies by us and others8-11) revealed that the main target organs of acute toxicity of DBCP were kidneys, testes, liver, lympho-hematopoietic tissues, intestine and epididymides.
The present study clearly revealed that only kidneys and testes were involved after repeated administration of relatively low doses of DBCP, while slight lesions appeared in other organs immediately after the exposure. The lesions in kidneys and testes were qualitatively and quantitatively similar throughout the experiment and were as severe as those caused by high doses of DBCP. These results show that the effects of DBCP on these tissues may be cumulative, resulting in irreversible damage. The kidneys and testes took a long time to recover from the toxic damage of DBCP,10,11) so slight but further adverse effects may be added before recovery when acutely subtoxic doses are administered repeatedly.
Renal lesions consisted of linings of large or bizarre giant cells with huge nuclei in the proximal tubules in the outer medulla. Similar changes appeared after a single high-dose treatment and after inhalation.11,13) The present study revealed nuclear enlargement of epithelial cells in the proximal tubules occurring at levels as low as 10 mg of DBCP/kg when administered repeatedly. This indicated that DBCP could produce adverse nuclear changes in kidneys even at low doses that did not cause acute abnormality.
Since DBCP is a potential alkylating agent,17) cumulative adverse effects may produce irreversible chromosomal aberration resulting in the formation of polyploid epithelial cells. Slight but significant elevation of serum creatinine concentration was noted in rats treated with 100 mg/kg, indicating a decline in the rate of glomerular filtration. Since the glomeruli appeared morphologically normal in these animals, the depressed filtration rate may be due to proximal tubular iniury which was characterized by degeneration and necrosis of the giant epithelial cells. It is further speculated that proteinuria and enzymuria may be caused by the breakedown of these tubular cells, but urinalyses were not done in the present study.
While previous acute toxicity study11) revealed a single dosing of 100 mg/kg DBCP produced a minimal effect on testis, marked atrophy of the seminiferous tubules occurred after repeated exposure of less than 100 mg/kg, indicating that low doses of DBCP may cumulatively produce irreversible lesions. There were some tubules containing reduced numbers of germinal cells, or degenerative spermatids that occasionally coalesced into multinucleated giant cells throughout the experiment.
This indicated that the testicular lesion might have been still in progress long after the exposure. Although morphological changes were first noticed in spermatids in the acute toxicity studyll) and high susceptibility of spermatids was indicated after the dominant lethal mutation study,18) those observation can not explain the progressive lesions in the testes. Recent studies indicated DBCP might produce testicular damage and infertility through a suppression of 13) Saegusa J, Hasegawa H, Kawai K. Toxicity of 1,2-dibromo-3-chloropropane (DBCP).
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